Release Date: 26/02/10 12:27 Summary: Full Year Results 2009 Price Sensitive: Yes Download Document 799.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%